Sleep on your left side for better brain detox

clinical trial to show this does not exist yet, but animal model do and the mechanism is there

Sleep contributes to the maintenance of overall health and well-being. There are a growing number of patients who have headache disorders that are significantly affected by poor sleep. This is a paradoxical relationship, whereby sleep deprivation or excess sleep leads to a worsening of headaches, yet sleep onset also alleviates ongoing headache pain. Currently, the mechanism of action remains controversial and poorly understood. The glymphatic system is a newly discovered perivascular network that encompasses the whole brain and is responsible for removing toxic proteins and waste metabolites from the brain as well as replenishing nutrition and energy. Recent studies have suggested that glymphatic dysfunction is a common underlying etiology of sleep disorders and headache pain. This study reviews the current literature on the relationship between the glymphatic system, sleep, and headaches, discusses their roles, and proposes acupuncture as a non-invasive way to focus on the glymphatic function to improve sleep quality and alleviate headache pain.

Source: Glymphatic System Dysfunction: A Novel Mediator of Sleep Disorders and Headaches

The Effect of Body Posture on Brain Glymphatic Transport 

We propose that the most popular sleep posture (lateral) has evolved to optimize waste removal during sleep and that posture must be considered in diagnostic imaging procedures developed in the future to assess CSF-ISF transport in humans.

The rodent brain removes waste better during sleep or anesthesia compared with the awake state. Animals exhibit different body posture during the awake and sleep states, which might affect the brain’s waste removal efficiency. We investigated the influence of body posture on brainwide transport of i …

Source: The Effect of Body Posture on Brain Glymphatic Transport – PubMed

DhivyTM, a carbidopa/levodopa fractionated tablet, is now available | American Parkinson Disease Association

A new formulation of carbidopa/levodopa 25/100, called DhivyTM, is now available. Manufactured by Avion Pharmaceuticals, its innovation is that it is scored into four sections allowing the pill to be easily cut into four equal parts. Each part contains 6.25 mg of carbidopa and 25 mg of levodopa.  The medication was approved by the US […]

Source: DhivyTM, a carbidopa/levodopa fractionated tablet, is now available | American Parkinson Disease Association

PD – Reduce Alpha-synuclein level, experimental protocol

Misfolded Alpha synuclein protein accumulate into aggregates (oligomers) and damage host cell. PD patients brain cells tend to express alpha synuclein in large amounts, Alpha-synucleinis assumed to have a role in the disease process, reducing Alpha-synuclein level may prevent neuron death and delay or reverse the disease process  More information >> [20]

The goal here is to normalize Alpha-synuclein level by using a simple protocol

Some notes:

  • Evidence is limited
  • Most references to the available evidence, is to scientific articles/research
  • Some “how to” information on also linked to aid implementation
  • The challenge – decision making under conditions of uncertainty (meaning – evidence is partial, what do you do?).
  • The solution (hopefully)  – use a collection of tools, each with limited evidence,   while probably not all work, most likely some will work

The protocol:

1 – Sweating – 3 liters/day or so, research show that Alpha-synuclein accumulate around sweat glands, it seems safe to assume that Alpha-synuclein is secreted via the sweat glands [18][1]

2 – Alpha-synuclein is also secreted in the urine, so you can detox by drinking a lot and using mild diuretics e.g. parsley [2]

List of natural diuretics >>

3 – Probiotics Bacillus Subtillis PXN21, “eats” Alpha-synuclein in the gut, this probiotics is in the market for a number of years, it’s probably safe Successful experiment in animal model(worms) [3].

Note: several bacteria species ( Lactobacillus and Enterococcus) interact with Levodopa ,and so , limit production of dopamine in the brain 

4 – Optimise detox at the cell level (from the cell, out),  raise glutathione level ( intravenous  or suppository glutatyon or eat the precursors e.g sulfur found in eggs and cruciferous vegetables).

Glutathione has other benefits( master detoxifier, master anti oxidant), so it’s a good idea to boost it anyway [19].

How to increase glutathione by Mark Hayman [17]

More ways to increase glutathione [4].

Note, the other direction, overexpression of Alpha synuclein cause a decrease in glutathione level [5].

5 –

Sleep issues may have an adverse effect on brain detox processes, in particular on alpha synuclein clearance [6].

Most of the brain detox is done by the Glymphatic System during sleep, give it time, 7-8 hours of sleep, don’t go to sleep to late. More information [7].

During sleep, glymphatic system activity is characterized by a 60% increase in the interstitial space and CSF flow (Jessen et al., 2015; Xie et al., 2013), and clearance of alpha-synuclein, along with other protein accumulations, from the brain (Iliff et al.,  2012[6].

6 – Improve autophagy by intermittent fasting, preferably keto-fast – meaning a ketogenic diet in a 12 hours or less, daily eating window Ketogenic diet induced autophagy [8].

7- Alpha synuclein is found in Vertebras e.g cow, pig, chicken. Those molecules are almost identical to the human Alpha-synuclein, but not 100% identical, and may have a role in creating a pathology, much like in prion infection, more information >>[9].

Consider avoiding vertebrates, especially brain, bone merrow, bone broth.

Eggs – OK, as far as I checked.

8 – Mannitol

Mannitol was shown to inhibit formation of Alpha-synuclein oligomers[10], and there are anecdotal improvement reports of PD patients.

A clinical experiment (n=36) did not show significant improvement

You can add Mannitol to your diet in the dosage used in the experiment – start with 2.5 gram 2 times a day, gradually increase to 9 grams 2 times a day.

Why use Mannitol if the experiment showed no improvement ?
If, for example, subjects have existing damage(accumulated before the experiment), but new damage build up is slowed by say 50%, that’s very good, but the subjects will not experience any improvement. Maybe after a long time, difference relative to the control group will begin to show

9 – HSP – Heat shock proteins

Heat shock proteins – are listed here as they slow down or inhibit the formation of Alpha-synuclein oligomers.

The level of HSP in the body rise in response to adverse conditions (ice bath, sauna…intense exercise)

Sulforaphane- a compound found mostly in broccoli sprouts, also increase level of HSP. Sulforaphane is available in supplement form

Sulforaphaneis also beneficial to brain health as it reduces inflammation, increase anti oxidant activity and more [13], so it’s a good idea to use it anyway.

Mannitol  also increase HSP level, this is one of  the suggested mechanisms of action that explain why it inhibits creation of Alpha-synuclein oligomers, and generally improves PD [11].

Different heat shock proteins bind α-Synuclein with distinct mechanisms and synergistically prevent its  amyloid aggregation

More information on Sulforaphane >>

HSP27 binds Alpha synuclein  >>[14]


Sulforaphane increase level of HSP27 >> [15]

also  Sulforaphane increase level of HSP70 >>

10 – High intensity exercise

Irisin, a hormone secreted into the blood during high endurance and aerobic exercise, reduces levels of alpha-synuclein and restores movement in mouse models of PD [22]

Clinical research showing beneficial effect of high intensity exercise in PD patients  [23]

11 – Ambroxol – an over-the-counter cough syrup

One of the major genetic risk factors believed to contribute to the development of PD is having a mutation in the gene called GBA1 (glucocerebrosidase). Unable to do its job correctly, this damaged gene leads to the build-up of unhealthy, misfolded clumps of alpha-synuclein in the brain. These clumps, called Lewy bodies, impact dopamine production and are the hallmark of PD.

A 2020 study published in JAMA Neurology, titled, “Ambroxol for the Treatment of Patients with Parkinson Disease with and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial” (Mullin et al., 2020), investigated whether an over-the-counter cough syrup, called Ambroxol, may be the key. [24]

What to expect ?

If there is existing damage, and the protocol manage to stop/delay/reduce  further damage, e.g. by 100%,  this would be a significant achievement, but will not show as reduced symptoms (assuming n=1, meaning you tried it on yourself and you don’t have a control group etc).

A healthy person loose about 1% of its dopaminergic neurons every adult year,  this will not present symptoms as symptoms start showing when 80% or more of the dopaminergic capacity is gone

In a PD patient who started the protocol with say  15% of its dopaminergic capacity, even in the case of 100% cleanup of alpha synuclein, he will still be on 15% capacity and 14% next year, so…[21]

Not saying this to discourage, I believe the protocol worth the effort, and can by you time. I believe solutions based on gene therapy and stem cell  technology will be available soon.

Measuring Alpha-synuclein level require biopsy, we don’t have this technology available, but based on what we know from animal models, the protocol should work, at list some of it.

Besides it’s effect on Alpha-synuclein, the protocol is expected to improve brain health through several mechanisms including  reduced inflammation, normalizing heavy metals and other toxins, reduce oxidative stress, improved insulin sensitivity… So…good idea to try it anyway.

One more thing, a quote from  coacher Tony Robins –

Take Massive Action


What do you think ? feedback welcome, please comment below

Sign up for updates  here >>
(you will get a confirmation email)

Want to try it ?  good luck !  ( needless to say,  it’s your responsibility )

Please fill free to contact with any issue




I collected the above set of tools, as they directly affect alpha-synuclein. Nevertheless, most those are very popular general health tools  e.g IM fasting, Keto, detox, sleep cycle compatible with circadian rhythm, Glutathione, Heat shock protein…

So, since they are popular, they seem to be safe.

[1] –

Gibbons, C. H., J. Garcia, N. Wang, L. C. Shih, and R. Freeman, 2016, The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease: Neurology, v. 87, no. 5, p. 505–512, doi:10.1212/wnl.0000000000002919.

‌‌[2] –

Giri, B., M. Seamon, A. Banerjee, S. Chauhan, S. Purohit, J. Morgan, B. Baban, and C. Wakade, 2021, Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease: Metabolic Brain Disease, v. 37, no. 6, p. 1687–1696, doi:10.1007/s11011-021-00735-2.

‌‌‌[3] –

Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation  -, 2022: <; (accessed October 6, 2022).

‌‌[4] –

Berkheiser, K., 2018, 10 Natural Ways to Increase Your Glutathione Levels: Healthline Media: <; (accessed October 6, 2022).

‌‌[5] –

Perfeito, R., M. Ribeiro, and A. C. Rego, 2016, Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells: Archives of Toxicology, v. 91, no. 3, p. 1245–1259, doi:10.1007/s00204-016-1788-6.

‌‌[6] –

Sundaram, S., R. L. Hughes, E. Peterson, E. M. Müller-Oehring, H. M. Brontë-Stewart, K. L. Poston, A. Faerman, C. Bhowmick, and T. Schulte, 2019, Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease: Neuroscience & Biobehavioral Reviews, v. 103, p. 305–315, doi:10.1016/j.neubiorev.2019.05.016.

‌‌[7] –

Raypole, C., 2020, How to “Detox” Your Brain (Hint: It’s Easier Than You Think): Healthline Media: <; (accessed October 6, 2022).

‌‌‌[8] –

Lindberg, S., 2018, Autophagy: What You Need to Know: Healthline Media: <; (accessed October 6, 2022).

‌‌‌[9] –,cow%2C%20and%20chicken%2C%20respectively.

‌‌[10] –

Linetsky, E., S. Abd Elhadi, M. Bauer, A. Gallant, M. Namnah, S. Weiss, D. Segal, R. Sharon, and D. Arkadir, 2022, Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson’s Disease: Frontiers in Neurology, v. 12, doi:10.3389/fneur.2021.716126.

‌‌‌[11] –

Linetsky, E., S. Abd Elhadi, M. Bauer, A. Gallant, M. Namnah, S. Weiss, D. Segal, R. Sharon, and D. Arkadir, 2022, Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson’s Disease: Frontiers in Neurology, v. 12, doi:10.3389/fneur.2021.716126.

‌‌‌[12] –,and%20different%20Hsps%20remains%20unclear.

‌‌[13] –

Sulforaphane, which is high in broccoli sprouts, clears away brain amyloid plaques and tau tangles and ameliorated memory defects in mice., 2019: <,jed%2Dw%2Dfahey&gt; (accessed October 6, 2022).

‌‌‌[14] –

Cox, D., D. R. Whiten, J. W. P. Brown, M. H. Horrocks, R. San Gil, C. M. Dobson, D. Klenerman, A. M. van Oijen, and H. Ecroyd, 2018, The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity: Journal of Biological Chemistry, v. 293, no. 12, p. 4486–4497, doi:10.1074/jbc.m117.813865.

‌‌‌‌[15] –

Gan, N., Y.-C. Wu, M. Brunet, C. Garrido, F.-L. Chung, C. Dai, and L. Mi, 2010, Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27: Journal of Biological Chemistry, v. 285, no. 46, p. 35528–35536, doi:10.1074/jbc.m110.152686.

‌‌‌‌[16] –

Schepici, G., P. Bramanti, and E. Mazzon, 2020, Efficacy of Sulforaphane in Neurodegenerative Diseases: International Journal of Molecular Sciences, v. 21, no. 22, p. 8637, doi:10.3390/ijms21228637.


Hyman, M., 2010, What is Glutathione and How Do I Get More of It? – Dr. Mark Hyman: <; (accessed October 9, 2022).


‌Wang, N., C. H. Gibbons, J. Lafo, and R. Freeman, 2013, -Synuclein in cutaneous autonomic nerves: Neurology, v. 81, no. 18, p. 1604–1610, doi:10.1212/wnl.0b013e3182a9f449.


Dringen, R., 2000, Metabolism and functions of glutathione in brain: Progress in Neurobiology, v. 62, no. 6, p. 649–671, doi:10.1016/s0301-0082(99)00060-x.


Fields, C. R., N. Bengoa-Vergniory, and R. Wade-Martins, 2019, Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease: Frontiers in Molecular Neuroscience, v. 12, doi:10.3389/fnmol.2019.00299.


Peters, R., 2006, Ageing and the brain: Postgraduate Medical Journal, v. 82, no. 964, p. 84–88, doi:10.1136/pgmj.2005.036665.


Exercise Hormone Halts Parkinson’s Disease Symptoms

23 –

Forced exercise 35% improvement, motor learning ? upregulate dopamine

24 – Ambroxol


Perspective on the Road toward Gene Therapy for Parkinson’s Disease

Source: Perspective on the Road toward Gene Therapy for Parkinson’s Disease

Results from the clinical trials may at a first look seem somewhat disappointing, but have brought the field to a state that safe delivery of viral vectors into the brain is feasible. Expression of a foreign (therapeutic) gene is possible and in none of the studies, long term exposure to the transgene has led to severe adverse events. With such a progression, delivery of the silver bullet still seems within reach.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease – PubMed

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases after Alzheimer’s disease (AD), afflicting adults above the age of sixty irrespective of gender, race, ethnicity, and social status. PD is characterized by motor dysfunctions, displaying resting tremor, rigidity, bradykine …

Source: Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease – PubMed

Low-Carbohydrate Diet Score and Coronary Artery Calcium Progression

Objective: To investigate whether low-carbohydrate diets (LCDs) were associated with coronary artery calcium (CAC) progression. Approach and Results: We included the participants who completed comput

Source: Low-Carbohydrate Diet Score and Coronary Artery Calcium Progression

Low carb diets – LCDs starting at a young age are associated with an increased risk of subsequent CAC progression, particularly when animal protein or fat are chosen to replace carbohydrates.